Singapore markets close in 45 minutes

TG Therapeutics, Inc. (TGTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
15.57+0.13 (+0.84%)
At close: 04:00PM EDT
15.87 +0.30 (+1.93%)
After hours: 05:36PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
12,672
12,672
-198,335
-348,101
-279,381
Depreciation & amortisation
423
423
515
494
374
Stock-based compensation
37,933
37,933
19,185
61,274
80,289
Change in working capital
-84,659
-84,659
-1,647
-12,216
-19,757
Accounts receivable
-51,093
-51,093
1,389
-1,389
0
Inventory
-36,938
-36,938
0
0
-
Accounts payable
-
-
-
-
11,631
Other working capital
-31,413
-31,413
-176,184
-296,035
-214,864
Other non-cash items
4,454
4,454
4,443
2,398
3,998
Net cash provided by operating activities
-31,413
-31,413
-176,170
-295,634
-214,507
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-14
-401
-357
Purchases of investments
-146,880
-146,880
-107,274
-55,531
-67,403
Sales/maturities of investments
96,229
96,229
87,275
55,600
43,250
Net cash used for investing activities
-50,651
-50,651
-20,013
-332
-24,510
Cash flows from financing activities
Debt repayment
0
0
-975
-30,000
0
Common stock issued
46,296
46,296
0
2,219
679,680
Dividends paid
-
-
-
0
0
Other financing activities
-125
-125
-
-1,016
-
Net cash used provided by (used for) financing activities
72,705
72,705
-391
41,419
679,827
Net change in cash
-9,359
-9,359
-196,574
-254,547
440,810
Cash at beginning of period
103,577
103,577
300,151
554,698
113,888
Cash at end of period
94,218
94,218
103,577
300,151
554,698
Free cash flow
Operating cash flow
-31,413
-31,413
-176,170
-295,634
-214,507
Capital expenditure
-
-
-14
-401
-357
Free cash flow
-31,413
-31,413
-176,184
-296,035
-214,864